These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26567039)

  • 21. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
    Rubin LR; Werner-Lin A; Sagi M; Cholst I; Stern R; Lilienthal D; Hurley K
    Hum Fertil (Camb); 2014 Sep; 17(3):159-64. PubMed ID: 25105219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.
    Vu JV; Llarena NC; Estevez SL; Moravek MB; Jeruss JS
    J Surg Oncol; 2017 Feb; 115(2):116-121. PubMed ID: 27966219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
    Nahshon C; Lavie O; Oron G
    J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
    Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
    Mor P; Brennenstuhl S; Metcalfe KA
    J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "I do not want my baby to suffer as I did"; prenatal and preimplantation genetic diagnosis for BRCA1/2 mutations: a case report and genetic counseling considerations.
    Dagan E; Gershoni-Baruch R; Kurolap A; Goldberg Y; Fried G
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):461-6. PubMed ID: 24915046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
    Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
    Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic counselor approaches to BRCA1/2 direct-to-consumer genetic testing results.
    Burke S; Mork M; Qualmann K; Woodson A; Jin Ha M; Arun B; Kaulfus M
    J Genet Couns; 2021 Jun; 30(3):803-812. PubMed ID: 33550665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
    Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
    Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
    Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
    Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.
    Dagan E; Birenbaum-Carmeli D; Friedman E; Feldman B
    J Genet Couns; 2017 Oct; 26(5):1070-1079. PubMed ID: 28265801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis.
    Kalfoglou AL; Scott J; Hudson K
    Reprod Biomed Online; 2005 Oct; 11(4):486-96. PubMed ID: 16274615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France.
    Gauna Cristaldo FB; Touzani R; Apostolidis T; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Fricker JP; Berthet P; Julian-Reynier C; Mancini J; Noguès C; Bouhnik AD
    Psychooncology; 2019 Sep; 28(9):1894-1900. PubMed ID: 31276266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants.
    Vuković P; Peccatori FA; Massarotti C; Miralles MS; Beketić-Orešković L; Lambertini M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103201. PubMed ID: 33333149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012.
    Chang J; Boulet SL; Jeng G; Flowers L; Kissin DM
    Fertil Steril; 2016 Feb; 105(2):394-400. PubMed ID: 26551441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prerequisites for preimplantation genetic diagnosis (PGD in carriers of mutations responsible for hereditary cancers].
    Hüttelová R; Kleibl Z; Rezátová J; Krutílková V; Foretová L; Novotný J; Kotlas J; Zikán M; Pohlreich P
    Klin Onkol; 2009; 22 Suppl():S69-74. PubMed ID: 19764403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.